Health warning labels on heated tobacco products and their impact on use intentions and risk perceptions: a cross-sectional study of adult tobacco users in the US and Israel

被引:1
作者
Duan, Zongshuan [1 ]
Levine, Hagai [2 ,3 ]
Bar-Zeev, Yael [2 ,3 ]
Cui, Yuxian [4 ]
LoParco, Cassidy R.
Wang, Yan [4 ,5 ]
Abroms, Lorien C. [4 ,5 ]
Khayat, Amal [2 ,3 ]
Berg, Carla J. [4 ,5 ]
机构
[1] Georgia State Univ, Sch Publ Hlth, Dept Populat Hlth Sci, Atlanta, GA USA
[2] Hebrew Univ Jerusalem, Fac Med, Braun Sch Publ Hlth & Community Med, Jerusalem, Israel
[3] Hadassah Med Ctr, Jerusalem, Israel
[4] George Washington Univ, Milken Inst Sch Publ Hlth, Dept Prevent & Community Hlth, Washington, DC 20052 USA
[5] George Washington Univ, George Washington Canc Ctr, Washington, DC 20052 USA
关键词
Heated tobacco products; Risk perceptions; Health communication; Tobacco control; CIGARETTE; REACTANCE;
D O I
10.1186/s13584-023-00582-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background Health warning labels (HWLs) represent an evidence-based tobacco control strategy; however, their application to heated tobacco products (HTPs) and related impacts are understudied. This study examined the impact of HTP HWLs on HTP use intentions and risk perceptions among current tobacco users.Methods We analyzed cross-sectional survey data from adults in the US and Israel reporting past-month tobacco use and awareness of HTPs (N = 424). Multivariate analyses examined: (1) sociodemographics in relation to self-reported impact of HTP HWLs (i.e., more concerned about HTP use, reassured, no effect [referent]) among those who noticed HTP HWLs (multinomial regressions); and (2) HWL impacts in relation to HTP use intentions and perceived addictiveness and harm (linear regressions).Results Among participants who noticed HTP HWLs (n = 372, 87.7%), 27.7% reported HWLs increased their concerns about HTP use, 22.6% were reassured about use, and 49.7% reported no effect. Factors associated with increased concern (vs. no effect) included other tobacco product use (aOR = 2.10, 95% CI 1.21-3.64) and being female (aOR = 1.77, 95% CI 1.03-3.05). Factors associated with being reassured about HTPs use (vs. no effect) included current HTP use (aOR = 2.11, 95% CI 1.11-4.00) and being from Israel (vs. US: aOR = 3.85, 95% CI 1.85-7.69), female (aOR = 1.91, 95% CI 1.07-3.42), and less educated (< college education: aOR = 2.57, 95% CI 1.42-4.63). Reporting that HWLs on HTPs increased concern (beta = 0.46, 95% CI 0.03-0.89) and reassured of use (beta = 0.94, 95% CI 0.47-1.41) were positively associated with HTP use intentions; no associations with risk perceptions were found.Conclusions Findings indicate that most tobacco users noticed HWLs on HTPs, but the majority reported no effect or being reassured of using HTPs, effects that were magnified for specific subgroups. Both increased concern and reassurance correlated with greater use intentions. Additional research should evaluate HTP HWL impacts and ensure effectiveness in communicating risks and discouraging use.
引用
收藏
页数:10
相关论文
共 52 条
  • [1] Anticipating IQOS market expansion in the United States
    Abroms, Lorien
    Levine, Hagai
    Romm, Katelyn
    Wysota, Christina
    Broniatowski, David
    Bar-Zeev, Yael
    Berg, Carla
    [J]. TOBACCO PREVENTION & CESSATION, 2022, 8
  • [2] [Anonymous], 2020, Global Adult Tobacco Survey (GATS): Core Questionnaire with Optional Questions
  • [3] [Anonymous], 2023, Reuters
  • [4] Impact of different health warning label and reduced exposure messages in IQOS ads on perceptions among US and Israeli adults
    Berg, Carla J.
    Duan, Zongshuan
    Wang, Yan
    Thrasher, James F.
    Abroms, Lorien C.
    Khayat, Amal
    Romm, Katelyn F.
    Levine, Hagai
    Bar-Zeev, Yael
    [J]. PREVENTIVE MEDICINE REPORTS, 2023, 33
  • [5] IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation
    Berg, Carla J.
    Romm, Katelyn F.
    Bar-Zeev, Yael
    Abroms, Lorien C.
    Klinkhammer, Katharina
    Wysota, Christina N.
    Khayat, Amal
    Broniatowski, David A.
    Levine, Hagai
    [J]. TOBACCO CONTROL, 2023, 32 (04) : 418 - 427
  • [6] IQOS Marketing in the US: The Need to Study the Impact of FDA Modified Exposure Authorization, Marketing Distribution Channels, and Potential Targeting of Consumers
    Berg, Carla J.
    Abroms, Lorien C.
    Levine, Hagai
    Romm, Katelyn F.
    Khayat, Amal
    Wysota, Christina N.
    Duan, Zongshuan
    Bar-Zeev, Yael
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (19)
  • [7] Informing iQOS Regulations in the United States: A Synthesis of What We Know
    Berg, Carla J.
    Bar-Zeev, Yael
    Levine, Hagai
    [J]. SAGE OPEN, 2020, 10 (01):
  • [8] Reduced-Risk Warnings Versus the US FDA-Mandated Addiction Warning: The Effects of E-Cigarette Warning Variations on Health Risk Perceptions
    Berry, Christopher
    Burton, Scot
    [J]. NICOTINE & TOBACCO RESEARCH, 2019, 21 (07) : 979 - 984
  • [9] Impact of graphic and text warnings on cigarette packs: findings from four countries over five years
    Borland, R.
    Wilson, N.
    Fong, G. T.
    Hammond, D.
    Cummings, K. M.
    Yong, H-H
    Hosking, W.
    Hastings, G.
    Thrasher, J.
    McNeill, A.
    [J]. TOBACCO CONTROL, 2009, 18 (05) : 358 - 364
  • [10] Campaign for Tobacco-Free Kids, Heated tobacco products definition and global market 2020